In collaboration with Bayer, MassBio is launching a Regulatory Center of Excellence. This is a new quarterly initiative to provide a forum for startups, biotechs, and research groups from academia to interact with experts on regulatory affairs. This event is meant to be an interactive platform for you to bring your key challenges to the discussion to better understand the evolving regulatory landscape. Our goal is to provide global regulatory insights on clinical development that will foster new innovative medicines for patients. Given the ongoing situation, our first event will be held virtually via Zoom.

Agenda:
1:00 - 1:05 pm     Welcome
1:05 - 1:15 pm     Introduction to the Center for Regulatory Excellence
1:15 - 1:35 pm     Engaging the US FDA on the Journey to Transforming Your Innovation Into a New Treatment Option
1:35 - 2:15 pm     Interactive Discussion

Moderators:

• Chuck Wilson, President & CEO of Unum Therapeutics, and Chair, MassBio Board of Directors
• Hanna Eilken, Strategic Alliances Director, Bayer

Bayer Panelists:

• Max Wegner, SVP, Head of Regulatory Affairs
• Chandra Ramanathan, Global Head, Pharma Research and Development Open Innovation
• Todd Paporello, VP, Head Regulatory Affairs Americas